Clinical Trials Directory

Trials / Completed

CompletedNCT00203333

Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death

Status
Completed
Phase
Study type
Observational
Enrollment
19 (actual)
Sponsor
Thomas Jefferson University · Academic / Other
Sex
All
Age
16 Years – 49 Years
Healthy volunteers
Not accepted

Summary

People with epilepsy are at a higher risk for sudden unexpected death than the general population. Sudden unexpected death in epilepsy (SUDEP) is a major cause of death in this population, accounting for 10-50% of deaths for those with epilepsy. The risk for SUDEP is particularly high for those with refractory epilepsy. Several lines of evidence support a cardiac mechanism for SUDEP. This study plans to determine: 1. the frequency and types of cardiac arrhythmias that occur in this population and 2. whether these are increased above the general population in the same age group. Additionally, these data will be correlated to specific clinical data, including seizure history, anticonvulsant medications, and any accompanying clinical symptoms.

Detailed description

By employing long-term electrocardiographic monitoring, this study plans to determine: 1. the frequency and types of cardiac arrhythmias that occur in patients with uncontrolled seizures and 2. whether these are increased above the general population in the same age group. The specific aims: 1. Identify the types, frequency, and duration of cardiac arrhythmias that occur in patients with refractory epilepsy and compare these data to available normative data. 2. Correlate abnormal heart rates and rhythms to specific clinical data: 1. seizure type, 2. seizure frequency, 3. probable location of seizure onset in the brain, when such data are available, 4. duration of seizures, and 5. type(s) and number of anticonvulsant medications being used. 3. Correlate cardiac arrhythmias to clinical symptoms

Conditions

Interventions

TypeNameDescription
DEVICEMedtronic REVEAL

Timeline

Start date
2002-04-01
Primary completion
2007-06-01
Completion
2010-01-01
First posted
2005-09-20
Last updated
2016-10-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00203333. Inclusion in this directory is not an endorsement.